Core Viewpoint - The stock price of Cuihua Jewelry (002731) has experienced a significant decline, closing at 12.84 yuan, down 10.02%, and has hit the limit down for two consecutive days, indicating market concerns about the company's financial health and performance outlook [1][2]. Trading Information Summary - On January 30, Cuihua Jewelry's stock closed at 12.84 yuan with a trading volume of 221,791,000 yuan, marking a continuous decline over two days and a drop of over 5% on two occasions in the last five trading days [2]. - In the first ten trading days, the net inflow of main funds was 43.66 million yuan, with a cumulative stock price increase of 0.85% during this period [2]. Fund Flow Analysis - On January 30, the main funds experienced a net outflow of 8.28 million yuan, while retail investors saw a net inflow of 18.01 million yuan, indicating a divergence in investor sentiment [3]. Performance Disclosure Highlights - Cuihua Jewelry has issued a performance forecast for 2025, estimating earnings per share between 0.08 yuan and 0.12 yuan, with net profit attributable to shareholders expected to be between 21 million yuan and 31 million yuan, reflecting a decline of 85.69% to 90.31% year-on-year [4]. - The company anticipates a significant increase in net profit excluding non-recurring gains and losses, projected to be between 162 million yuan and 242 million yuan, representing a year-on-year growth of 154.81% to 280.64% [4]. Company Announcements Summary - The controlling shareholder, Chen Siwei, has had 21.67% of his shares frozen due to overdue bank loans, which are linked to litigation involving company guarantees [6]. - The company has faced inquiries regarding its gold inventory and overdue loans, with the management emphasizing adherence to disclosure regulations and the importance of official announcements for accurate information [5][7][8].

Group 1 - The core viewpoint of the news is that Aomei Medical (002950) is experiencing a significant decline in expected profits for 2025, primarily due to asset impairment and credit provisions [1][2][3] Group 2 - As of January 30, 2026, Aomei Medical's stock closed at 11.56 yuan, down 1.87%, with a turnover rate of 2.6% and a trading volume of 117,600 shares, amounting to a transaction value of 136 million yuan [1] - The company anticipates a net profit attributable to shareholders for 2025 between 215.50 million yuan and 257.50 million yuan, representing a year-on-year decline of 30.16% to 41.55% [1][3] - Aomei Medical plans to recognize a total asset impairment provision of approximately 271 million yuan, which will reduce the total profit for 2025 by 208.63 million yuan [2][3] - The company expects its earnings per share for 2025 to be between 0.35 yuan and 0.41 yuan, with a net profit after deducting non-recurring gains and losses projected between 18 million yuan and 22.15 million yuan [1]

截至2026年1月30日收盘，中国东航(600115)报收于5.44元，上涨0.74%，换手率0.85%，成交量144.68万 手，成交额7.87亿元。 当日关注点 交易信息汇总资金流向 1月30日主力资金净流出7158.07万元，占总成交额9.09%；游资资金净流入929.02万元，占总成交额 1.18%；散户资金净流入6229.06万元，占总成交额7.91%。 业绩披露要点业绩预告 中国东航发布业绩预告，预计2025年全年扣非后净利润亏损27亿元至33亿元。中国东航发布业绩预告， 预计2025年全年归属净利润亏损13亿元至18亿元。 公司公告汇总 中国东方航空股份有限公司2025年度业绩预告 中国东方航空股份有限公司预计2025年度利润总额约为人民币2亿元至3亿元，实现扭亏为盈。归属于上 市公司股东的净利润预计为人民币-13亿元至-18亿元，扣除非经常性损益后净利润预计为人民币-27亿元 至-33亿元。主要原因为转回前期可抵扣亏损形成的递延所得税资产，增加所得税费用，导致净利润为 负值。2024年度利润总额为-39.04亿元，上年同期业绩亏损。本业绩预告未经注册会计师审计。 以上内容为证券之星据公开信息整 ...

Core Viewpoint - ST京蓝 is experiencing significant financial challenges, with projected losses for 2025 and ongoing stock trading volatility, leading to increased scrutiny from regulatory bodies [2][3][4] Trading Information Summary - As of January 30, 2026, ST京蓝's stock closed at 2.12 yuan, up 1.92%, with a turnover rate of 14.8% and a trading volume of 3.3825 million shares, amounting to a transaction value of 720 million yuan [1] - On January 30, 2026, the net outflow of main funds was 114 million yuan, while retail and speculative funds saw net inflows of 60.81 million yuan and 53.42 million yuan, respectively [1][3] - ST京蓝 was listed on the "龙虎榜" due to a cumulative price deviation of over 12% for three consecutive trading days, marking its second appearance on the list in five days [1][3] Performance Disclosure Highlights - ST京蓝 forecasts a total revenue for 2025 between 440 million yuan and 510 million yuan, with an expected loss per share ranging from 0.05 yuan to 0.08 yuan [2] - The projected net loss attributable to shareholders for 2025 is between 160 million yuan and 230 million yuan, representing a decline of 45.60% to 109.30% compared to the previous year [2] - The anticipated total profit loss is between 180 million yuan and 260 million yuan, with a net profit loss after excluding non-recurring gains and losses expected to be between 150 million yuan and 220 million yuan [2] Company Announcements Summary - The controlling shareholder, Yunnan Jiajun Target Material Technology Co., Ltd., has pledged 26.4 million shares of ST京蓝, totaling 540 million shares pledged, which constitutes 18.51% of the company's total share capital [3] - ST京蓝's stock has been under other risk warnings since July 9, 2025, following the receipt of an administrative penalty notice from the China Securities Regulatory Commission [4]

丨证券研究报告丨 行业研究丨行业周报丨投资银行业与经纪业 [Table_Title] 业绩预告期仍为重点配置时期 报告要点 [Table_Summary] 本周非银板块整体表现较强，部分公司披露 2025 年业绩预告，整体延续高增态势。券商方面， 本周证监会召开资本市场"十五五"规划上市公司座谈会，另外市场交投有所回升，整体维持 历史高位；保险方面，中长期来看三季报以来印证了存款搬家、增配权益和新单成本改善逻辑， 中长期 ROE 改善确定性进一步提升，估值有望加速修复，健康慢牛下建议积极增配保险。 分析师及联系人 [Table_Author] SAC：S0490519080007 SAC：S0490521020001 SFC：BUV596 吴一凡 谢宇尘 盛晓双 请阅读最后评级说明和重要声明 %% %% research.95579.com 1 投资银行业与经纪业 cjzqdt11111 [Table_Title2] 业绩预告期仍为重点配置时期 [Table_Summary2] 核心观点 1）本周非银板块整体表现较强，部分公司披露 2025 年业绩预告，整体延续高增态势。券商方 面，本周证监会召开资本市场"十 ...

Investment Rating - The investment rating for the company is "Accumulate" with a target price of 73.10 CNY [6]. Core Insights - The company has released its earnings forecast for 2025, projecting a net profit attributable to shareholders between 1.67 billion to 1.85 billion CNY, representing a year-on-year increase of 54.0% to 70.6% [13]. - The company is expected to face short-term pressure due to the transition to new national standards for electric two-wheelers in Q4 2025, while the lawnmower segment is anticipated to maintain high growth [2][13]. - The forecasted net profit for Q4 2025 is expected to be between -0.12 billion to +0.06 billion CNY, indicating a significant decline compared to the previous year [13]. Financial Summary - Total revenue is projected to grow from 10.22 billion CNY in 2023 to 21.41 billion CNY in 2025, reflecting a growth rate of 50.8% [5]. - Net profit attributable to shareholders is expected to increase from 598 million CNY in 2023 to 1.76 billion CNY in 2025, with a growth rate of 62.4% [5]. - Earnings per share (EPS) is forecasted to rise from 8.29 CNY in 2023 to 24.40 CNY in 2025 [5]. - The return on equity (ROE) is projected to reach 37.9% in 2025, up from 11.0% in 2023 [5]. Business Outlook - The company is focusing on the electric two-wheeler market, which is expected to recover in Q1 2026 after facing challenges in Q4 2025 due to new regulations [13]. - The lawnmower segment is expected to maintain strong growth, with the company accelerating shipments in response to market demands [13]. - Other business segments, including scooters and balance bikes, are projected to show steady growth, contributing to the company's long-term resilience [13].

Core Viewpoint - *ST HuKe's stock price increased by 11.7% to 4.01 yuan, with a total market value of 1.319 billion yuan, ranking 13th in the trade sector and 5175th in the A-share market [1] Performance Disclosure Highlights - The company expects 2025 annual operating revenue to be between 7.5 million and 11 million yuan, with the same range for net profit attributable to shareholders estimated between 3.9 million and 5.8 million yuan [1][3] - The net profit after deducting non-recurring items is projected to be between 280,000 and 420,000 yuan [1] Company Announcement Summary - The company received a notice from the China Securities Regulatory Commission regarding an investigation for suspected violations of information disclosure laws [1][3] - If the net profit for 2025 is negative and revenue is below 300 million yuan, the company's stock will be delisted [1][3] - The former controlling shareholder's fund occupation balance is 348.61 million yuan, accounting for 921.63% of the latest audited net assets [1][3] - The company has made a provision for bad debts of 89.9% on prepaid petrochemical payments, indicating further impairment risks [1]

灿瑞科技发布业绩预告，预计2025年全年归属净利润亏损4800万元至6800万元；预计全年营业收入为 5.8亿元至6.6亿元；扣非后净利润预计亏损7800万元至1.08亿元。 公司公告汇总 上海灿瑞科技股份有限公司预计2025年度实现营业收入58,000万元至66,000万元，同比增长2.60%到 16.75%；归属于母公司所有者的净利润为-4,800万元至-6,800万元，上年同期为-5,231.70万元；扣除非 经常性损益后的净利润为-7,800万元至-10,800万元。业绩变动主要因消费电子行业复苏带动销量上升， 美元兑人民币汇率下降影响净利润，以及银行利率下调导致理财收益减少。本次业绩预告未经注册会计 师审计，最终数据以正式披露的经审计年报为准。 截至2026年1月30日收盘，灿瑞科技（688061）报收于37.51元，较上周的37.84元下跌0.87%。本周，灿 瑞科技1月28日盘中最高价报38.53元。1月27日盘中最低价报35.8元。灿瑞科技当前最新总市值43.1亿 元，在半导体板块市值排名162/171，在两市A股市值排名3887/5184。 本周关注点 交易信息汇总 1月29日灿瑞科技发生1 ...

Core Viewpoint - International Industry (000159) is expected to achieve a net profit of approximately 36 million yuan for the year 2025, marking a turnaround from a previous loss [1][3] Performance Disclosure Highlights - The company forecasts an earnings per share of approximately 0.0749 yuan for 2025, compared to a loss of 0.9128 yuan per share in the same period last year [1] - The expected net profit after deducting non-recurring gains and losses is approximately 36.7 million yuan, which represents a decline of about 31.90% compared to the previous year's figure of 53.89 million yuan [1][3] Company Announcement Summary - The anticipated net profit for 2025 is a significant improvement from a loss of 43.88 million yuan in the same period last year, indicating a successful turnaround [1] - The performance change is primarily attributed to a substantial loss incurred in the previous year due to the sale of a real estate subsidiary's equity [1]

Core Viewpoint - The company, Gaoling Information, is expected to report significant losses for the year 2025, with a projected net profit loss ranging from 33 million to 42.9 million yuan, alongside a decline in revenue compared to the previous year [2][3][5]. Group 1: Performance Disclosure Highlights - Gaoling Information forecasts a net profit loss of 33 million to 42.9 million yuan for the year 2025 [2][5]. - The expected operating revenue for 2025 is projected to be between 220 million and 242 million yuan, reflecting a year-on-year decline of 9.19% to 17.44% [3]. - The company anticipates a non-recurring net profit loss of 60 million to 78 million yuan, with a year-on-year reduction in losses of 13.50% to 33.46% [3]. Group 2: Company Announcements Summary - The controlling shareholder of Gaoling Information has changed its name and increased its registered capital from 10 million to 30 million yuan, with no change in shareholding proportions [3][5]. - Core technical personnel, Wang Xianfa, has left the company for personal reasons, but the company asserts that its research and development capabilities remain unaffected [3][5].